🔎 Trials Near Me

Gara Jalqabaatti › Sindroomii Bronchiolitis Obliterans › Massachusetts

Qorannoo klinikaalii Sindroomii Bronchiolitis Obliterans Massachusetts keessatti

Qorannoo 14 Sindroomii Bronchiolitis Obliterans f Massachusetts keessatti hirmaatuu jiru.

Magaalota Massachusetts keessatti

Takkalaa qorannoo (Ingiliffa)

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

  • Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07011810

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

  • Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07116031

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

  • Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT05996627

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06585774

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

  • Massachusetts Cancer Research Center, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05919511

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

  • Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT06991361

Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD

  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 7 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07434869

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 16-Wax-2026 · NCT04710576

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05922761

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06615050

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

  • Joined Bio, Lexington
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT07128966

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Bit-2026 · NCT05236062

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT06619561

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2025 · NCT06462365

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.